Ipca Laboratories
IPCALAB · Pharma > Pharmaceuticals & Drugs · Chairman: Premchand Godha · MD: Premchand Godha · Listing date: Oct. 24, 1994 · Employees: 14574 · Mumbai · http://www.ipca.com

Stock Price vs Company Growth
1d
0.5%
1w
1.7%
1m
4.3%
3m
8.8%
6m
11.2%
1y
18.7%
5y
12.1%
10y
15.8%
all
19.7%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 1,449 0.5%
1,320
1,520
Company Overview

Sales
8,940 Cr
Growth: 16.3%
Profit after Tax
738 Cr
Growth: 1.1%
Large Cap
36,768 Cr
P/E: 49.8x
Industry P/E: 33.5x
Fundamentals

Sales (Cr) ₹ 8,940
Growth 16.3%
EBITDA 19.3%
P/S 4.1x
Dividend 0.3%
P/E 49.8x
Book Value ₹ 274
PEG Ratio 3.1x
ROE 10.8%
P/B 5.3x
Shareholding Pattern

Institutions
Dsp Midcap Fund
4.58 %
Hdfc Trustee Company Ltd - A/C Hdfc Mid - Capopportunities Fund
3.1 %
L And T Mutual Fund Trustee Ltd-L And T Mid Cap Fund
2.32 %
Icici Prudential Pharma Healthcare And Diaganostics (P.H.D) Fund
2.19 %
Hdfc Life Insurance Company Limited
2.02 %
Promoters
Kaygee Investments Pvt. Ltd.
21.47 %
Kaygee Laboratories Pvt. Ltd.
6.61 %
Chandurkar Investments Pvt. Ltd.
5.5 %
Paschim Chemicals Pvt. Ltd.
4.0 %
Premchand Godha
2.29 %
Others
Iepf
0.29 %
Llp
0.02 %
Increase    Decrease    No change
Company Profile Detailed

Ipca Laboratories is engaged in manufacturing of active pharmaceutical ingredients and formulations. Services and productsAPI- Ipca produces various APIs at its production facilities. Its core strategic focus has been on backward integration, resulting in superior supply chain reliability and cost competitiveness in a dynamic market. Ipca has also emerged as one of India’s top exporters of APIs, serving in many countries around the globe.
Investors (99)
Followers (11)